| Title |
Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL
|
|---|---|
| Published in |
Nature Medicine, September 2007
|
| DOI | 10.1038/nm1627 |
| Pubmed ID | |
| Authors |
Klaus W Wagner, Elizabeth A Punnoose, Thomas Januario, David A Lawrence, Robert M Pitti, Kate Lancaster, Dori Lee, Melissa von Goetz, Sharon Fong Yee, Klara Totpal, Ling Huw, Viswanatham Katta, Guy Cavet, Sarah G Hymowitz, Lukas Amler, Avi Ashkenazi |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Mexico | 1 | 33% |
| Unknown | 2 | 67% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Scientists | 2 | 67% |
| Members of the public | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 3 | 1% |
| Germany | 1 | <1% |
| Singapore | 1 | <1% |
| Argentina | 1 | <1% |
| Mexico | 1 | <1% |
| Japan | 1 | <1% |
| Poland | 1 | <1% |
| Unknown | 196 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 57 | 28% |
| Researcher | 48 | 23% |
| Student > Master | 24 | 12% |
| Student > Doctoral Student | 13 | 6% |
| Student > Bachelor | 12 | 6% |
| Other | 27 | 13% |
| Unknown | 24 | 12% |
| Readers by discipline | Count | As % |
|---|---|---|
| Agricultural and Biological Sciences | 73 | 36% |
| Biochemistry, Genetics and Molecular Biology | 39 | 19% |
| Medicine and Dentistry | 19 | 9% |
| Immunology and Microbiology | 12 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 3% |
| Other | 23 | 11% |
| Unknown | 32 | 16% |
Attention Score in Context
This research output has an Altmetric Attention Score of 11. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 November 2022.
All research outputs
#3,265,850
of 25,383,344 outputs
Outputs from Nature Medicine
#4,691
of 9,296 outputs
Outputs of similar age
#8,151
of 81,583 outputs
Outputs of similar age from Nature Medicine
#23
of 58 outputs
Altmetric has tracked 25,383,344 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 9,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 105.1. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 81,583 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 58 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 62% of its contemporaries.